The U.S. National Academy of Medicine, National Academy of Sciences, and the UK’s Royal Society have formed the The International Commission on the Clinical Use of Human Germline Genome Editing to provide guidance for heritable genome editing also known as Germline editing. The committee issued a report with 11 recommendations that address specific ethical and safety issues. These important considerations also create significant challenges for U.S. health and technology policy.
Learn more – The U.S. must do some heavy lifting to prepare for heritable genome editing
CITI Program’s Tech Ethics and CRISPR Content
Technology, Ethics, and Regulations
Through this dynamic course, learners will explore a range of technologies that have received significant global attention, with a focus on the ethical issues and governance approaches affecting those technologies.
View Course Details
Ethics & Policy Issues in CRISPR Gene Editing
In this webinar, learners will trace the international and U.S. policy and ethics responses to CRISPR technology use in humans, noting how those responses compare with past responses to related technologies.
View Webinar Details
